Hypertension and ischemic cardiovascular disease in Turner syndrome

International Congress Series

Volumn 1298, Issue , 2006, Pages 174-179

  Gravholt, Claus Højbjerg ^a   Hjerrild, Britta ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Delay; Epidemiology; Incidence; Morbidity, diagnosis; Mortality; Prevalence

Indexed keywords

EID: 33748889726     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2006.06.005     Document Type: Article

References (38)

1. Gotzsche C.O., et al. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch. Dis. Child. 71 (1994) 433-436
2. Mazzanti L., and Cacciari E. Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J. Pediatr. 133 5 (1998) 688-692
3. Ho V.B., et al. Major vascular anomalies in turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110 12 (2004) 1694-1700
4. Nathwani N.C., et al. Blood pressure and Turner syndrome. Clin. Endocrinol. (Oxf.) 52 3 (2000) 363-370
5. Gravholt C.H., et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner syndrome: the impact of sex hormone replacement. Diabetes Care 21 7 (1998) 1062-1070
6. Elsheikh M., et al. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin. Endocrinol. (Oxf.) 54 1 (2001) 69-73
7. Sybert V.P. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 101 1 (1998) E11-E17
8. Gravholt C.H., et al. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J. Hypertens. 24 (2006) 353-360
9. Virdis R., et al. Blood pressure behaviour and control in Turner syndrome. Clin. Exp. Hypertens., A 8 4-5 (1986) 787-791
10. Nathwani N.C., et al. The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clin. Endocrinol. (Oxf.) 52 3 (2000) 371-377
11. Bilge I., et al. Frequency of renal malformations in Turner syndrome: analysis of 82 Turkish children. Pediatr. Nephrol. 14 12 (2000) 1111-1114
12. Price W.H., Lauder I.J., and Wilson J. The electrocardiogram and sex chromosome aneuploidy. Clin. Genet. 6 1 (1974) 1-14
13. Bondy C.A., et al. Prolongation of the cardiac QTc interval in Turner syndrome. Medicine (Baltimore) 85 2 (2006) 75-81
14. Shores J., et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N. Engl. J. Med. 330 19 (1994) 1335-1341
15. Ross J.L., et al. Lipid abnormalities in Turner syndrome. J. Pediatr. 126 (1995) 242-245
16. Gravholt C.H., et al. Morbidity in Turner syndrome. J. Clin. Epidemiol. 51 2 (1998) 147-158
17. Swerdlow A.J., et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann. Hum. Genet. 65 Pt 2 (2001) 177-188
18. Gravholt C.H., et al. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. Atherosclerosis 150 (2000) 201-208
19. Landin-Wilhelmsen K., Bryman I., and Wilhelmsen L. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J. Clin. Endocrinol. Metab. 86 9 (2001) 4166-4170
20. Ostberg J.E., et al. Adipokine dysregulation in Turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J. Clin. Endocrinol. Metab. 90 5 (2005) 2948-2953
21. Van P.L., Bakalov V.K., and Bondy C.A. Monosomy for the X-chromosome is associated with an atherogenic lipid profile. J. Clin. Endocrinol. Metab. (2006) [Epub ahead of print, May 16]
22. Arem R., and Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch. Intern. Med. 150 (1990) 2097-2100
23. Ostberg J.E., et al. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J. Clin. Endocrinol. Metab. 89 12 (2004) 5966-5971
24. Andersen N.H., et al. Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study. Clin. Sci. (Lond.) 105 1 (2003) 59-66
25. Poulsen S.H., et al. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. J. Am. Soc. Echocardiogr. 16 7 (2003) 724-731
26. Ganau A., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J. Am. Coll. Cardiol. 19 7 (1992) 1550-1558
27. Poulsen S.H., et al. Evaluation and prognostic significance of left ventricular diastolic function assessed by Doppler echocardiography in the early phase of a first acute myocardial infarction. Eur. Heart J. 18 12 (1997) 1882-1889
28. Andersen N.H., et al. Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performance. Eur. J. Echocardiog. 4 4 (2003) 306-312
29. Andersen N.H., et al. Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitus. Diabet. Med. 22 9 (2005) 1218-1225
30. Barr Jr. M., and Oman-Ganes L. Turner Syndrome morphology and morphometrics: cardiac hypoplasia as a cause of midgestation death. Teratology 66 2 (2002) 65-72
31. Gravholt C.H., et al. The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. Eur. J. Endocrinol. 150 3 (2004) 355-362
32. Gravholt C.H., et al. Body composition and physical fitness are major determinants of the growth hormone-IGF axis aberrations in adult Turner syndrome, with important modulations by treatment with 17-beta-estradiol. J. Clin. Endocrinol. Metab. 82 8 (1997) 2570-2577
33. Holl R.W., et al. Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients. Eur. J. Pediatr. 153 (1994) 11-16
34. Gravholt C.H., et al. Short term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity. A randomized double-blind, placebo-controlled cross-over study. Pediatrics 110 5 (2002) 889-896
35. Gravholt C.H., et al. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome. Clin. Endocrinol. (Oxf.) 62 5 (2005) 616-622
36. Ostberg J.E., et al. Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J. Clin. Endocrinol. Metab. 90 5 (2005) 2631-2635
37. Van P.L., et al. Chromosome, visceral adiposity, and lipid profile. JAMA 295 12 (2006) 1373-1374
38. N.H. Andersen, et al., Subclinical left ventricular dysfunction in normotensive women with Turner's syndrome. Heart, in press.